Sign in

CIK 0001576280

  • Large accelerated filer

Guardant Health, Inc.

Sign in to watch
Ticker
GH
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454139254
Phone
+1 855-698-8887
Business address
3100 HANOVER STREET, PALO ALTO, CA, 94304
  1. 4 Option exercise Director acquired 4,435 shares (option exercise)
  2. 4 Option exercise Director acquired 4,203 shares (option exercise)
  3. 4 Option exercise Director acquired 5,092 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes Chief Information Officer gave up 314 shares (to pay taxes)
  6. 4 Planned sale Director sold 116 shares at $130.19 ($15,102)
  7. 4 Shares withheld for taxes Chief Legal Officer gave up 535 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Commercial Officer gave up 594 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 1,096 shares (to pay taxes)
  10. 4 Open-market sale Chief Information Officer sold 3,418 shares at $130.24 ($445,156)
  11. 4 Open-market sale Chief Information Officer sold 5,000 shares at $130.41 ($652,030)
  12. 4 Open-market sale Co-Chief Executive Officer sold 100,000 shares at an average $126.30 ($12,629,969)
  13. 4 Open-market sale Chief Financial Officer sold 2,000 shares at $128.62 ($257,241)
  14. 4 Open-market sale Director sold 9,294 shares at $132.51 ($1,231,522)
  15. 4 Planned sale Director sold 10,000 shares at an average $126.98 ($1,269,809)
  16. 4 Option exercise Director acquired 154 shares (option exercise)
  17. 4 Open-market sale Director sold 1,000 shares at $130.06 ($130,060)
  18. 4 Planned sale Chief Legal Officer sold 10,000 shares at an average $125.08 ($1,250,836)
  19. 4 Open-market sale Chief Commercial Officer sold 24,406 shares at $118.67 ($2,896,360)
  20. 4 Planned sale Chief Legal Officer sold 20,000 shares at an average $106.51 ($2,130,229)

Page 4 of 44 · 876 filings